Bank of Montreal
PROF

Bank of Montreal’s Profound Medical PROF Stock Holding History

Bank of Montreal’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.7K Buy
13,047
+1,305
+11% +$8.77K ﹤0.01% 3275
2026
Q1 		$75.1K Hold
11,742
– – ﹤0.01% 3198
2025
Q4 		$92.1K Buy
11,742
+6
+0.1% +$39 ﹤0.01% 3072
2025
Q3 		$57.3K Buy
11,736
+54
+0.5% +$276 ﹤0.01% 3084
2025
Q2 		$69.5K Hold
11,682
– – ﹤0.01% 3078
2025
Q1 		$66.7K Sell
11,682
-14
-0.1% -$97 ﹤0.01% 3011
2024
Q4 		$87.8K Sell
11,696
-2,551
-18% -$19.6K ﹤0.01% 2986
2024
Q3 		$113K Buy
14,247
+2,577
+22% +$23.3K ﹤0.01% 3207
2024
Q2 		$104K Buy
11,670
+135
+1% +$1.09K ﹤0.01% 3223
2024
Q1 		$98.3K Sell
11,535
-419
-4% -$3.5K ﹤0.01% 3289
2023
Q4 		$102K Sell
11,954
-93
-0.8% -$883 ﹤0.01% 3372
2023
Q3 		$107K Sell
12,047
-24
-0.2% -$249 ﹤0.01% 3263
2023
Q2 		$159K Sell
12,071
-366
-3% -$4.54K ﹤0.01% 3299
2023
Q1 		$127K Sell
12,437
-22,354
-64% -$259K ﹤0.01% 3178
2022
Q4 		$378K Buy
34,791
+121
+0.3% +$660 ﹤0.01% 2775
2022
Q3 		$174K Buy
34,670
+2,447
+8% +$16.5K ﹤0.01% 3264
2022
Q2 		$280K Sell
32,223
-1,154
-3% -$9.13K ﹤0.01% 3051
2022
Q1 		$318K Buy
33,377
+253
+0.8% +$2.44K ﹤0.01% 3153
2021
Q4 		$395K Buy
33,124
+4,096
+14% +$51.2K ﹤0.01% 2566
2021
Q3 		$451K Sell
29,028
-39,144
-57% -$596K ﹤0.01% 2933
2021
Q2 		$1.22M Buy
68,172
+10
+0% +$186 ﹤0.01% 2358
2021
Q1 		$1.34M Sell
68,162
-2,629
-4% -$63K ﹤0.01% 1990
2020
Q4 		$1.77M Buy
70,791
+9,527
+16% +$175K ﹤0.01% 1886
2020
Q3 		$1.02M Buy
61,264
+41,517
+210% +$660K ﹤0.01% 1968
2020
Q2 		$352K Sell
19,747
-1,003
-5% -$12.7K ﹤0.01% 2448
2020
Q1 		$201K Buy
20,750
+9,753
+89% +$126K ﹤0.01% 2326
2019
Q4 		$120K Buy
+10,997
New +$101K ﹤0.01% 3410

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Bank of Montreal's PROF Position: Q2 2026 in Review

Bank of Montreal increased its Profound Medical (PROF) stake by 11% in Q2 2026, buying an estimated $8.77K and bringing the position to 13,047 shares worth $86.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3275.

Bank of Montreal first reported a position in PROF in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.77M in Q4 2020. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Bank of Montreal held 13,047 shares of Profound Medical worth $86.7K as of Q2 2026.
  • Bank of Montreal bought 1,305 Profound Medical shares in Q2 2026, an estimated $8.77K.
  • Profound Medical made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3275 holding.
  • Bank of Montreal first reported a position in Profound Medical in Q4 2019 and has held it in 27 quarters since.
  • Bank of Montreal's Profound Medical position peaked at $1.77M in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.